Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Loza

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
ACR Open Rheumatology|July 4, 2026
Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over TimeLoqmane Seridi, Eugene Myshkin, Erika Noss, et al.
American Journal of Respiratory Cell and Molecular Biology|December 9, 2008
Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscleAnna M Misior, Deepak A Deshpande, Matthew J Loza, et al.
NPJ Systems Biology and Applications|June 27, 2017
Integrating personalized gene expression profiles into predictive disease-associated gene poolsJörg Menche, Emre Guney, Amitabh Sharma, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 25, 2010
Outcome after percutaneous endoscopic gastrostomy in children and young adultsJohn E Fortunato, April L Troy, Carmen Cuffari, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human studyBart van Hartingsveldt, Ivo P Nnane, Esther Bouman-Thio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 7, 2022
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military PersonnelMatthew J Loza, Sunil Nagpal, Suzanne Cole, et al.
Plos Computational Biology|May 1, 2019
I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatmentStelios Pavlidis, Calixte Monast, Matthew J Loza, et al.
RMD Open|May 20, 2021
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trialsKristen Sweet, Qingxuan Song, Matthew J Loza, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 14, 2018
A phase 2a study of toreforant, a histamine H<sub>4</sub> receptor antagonist, in eosinophilic asthmaAlexa P Kollmeier, Elliot S Barnathan, Christopher O'Brien, et al.
Annals of the American Thoracic Society|March 31, 2016
Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma StudiesMatthew J Loza, Ian Adcock, Charles Auffray, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
ACR Open Rheumatology|July 4, 2026
Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over TimeLoqmane Seridi, Eugene Myshkin, Erika Noss, et al.
American Journal of Respiratory Cell and Molecular Biology|December 9, 2008
Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscleAnna M Misior, Deepak A Deshpande, Matthew J Loza, et al.
NPJ Systems Biology and Applications|June 27, 2017
Integrating personalized gene expression profiles into predictive disease-associated gene poolsJörg Menche, Emre Guney, Amitabh Sharma, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 25, 2010
Outcome after percutaneous endoscopic gastrostomy in children and young adultsJohn E Fortunato, April L Troy, Carmen Cuffari, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human studyBart van Hartingsveldt, Ivo P Nnane, Esther Bouman-Thio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 7, 2022
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military PersonnelMatthew J Loza, Sunil Nagpal, Suzanne Cole, et al.
Plos Computational Biology|May 1, 2019
I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatmentStelios Pavlidis, Calixte Monast, Matthew J Loza, et al.
RMD Open|May 20, 2021
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trialsKristen Sweet, Qingxuan Song, Matthew J Loza, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 14, 2018
A phase 2a study of toreforant, a histamine H<sub>4</sub> receptor antagonist, in eosinophilic asthmaAlexa P Kollmeier, Elliot S Barnathan, Christopher O'Brien, et al.
Annals of the American Thoracic Society|March 31, 2016
Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma StudiesMatthew J Loza, Ian Adcock, Charles Auffray, et al.
Pageof 6